Načítá se...
Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury
Sepsis-associated acute kidney injury (SA-AKI) is associated with high mortality rates, but clinicians lack effective treatments except supportive care or renal replacement therapies. Recently, histone deacetylase (HDAC) inhibitors have been recognized as potential treatments for acute kidney injury...
Uloženo v:
| Vydáno v: | Am J Physiol Renal Physiol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Physiological Society
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7792695/ https://ncbi.nlm.nih.gov/pubmed/33017186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00405.2020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|